Alexandra Legge1, Steve Doucette1, John G Hanly2. 1. From the Division of Rheumatology, Department of Medicine, and Department of Pathology, Nova Scotia Health Authority, Dalhousie University; Research Methods Unit, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.A. Legge, MD, Department of Medicine, Nova Scotia Health Authority, Dalhousie University; S. Doucette, MSc, Research Methods Unit, Nova Scotia Health Authority; J.G. Hanly, MD, FRCPC, Division of Rheumatology, Department of Medicine, and Department of Pathology, Nova Scotia Health Authority, Dalhousie University. 2. From the Division of Rheumatology, Department of Medicine, and Department of Pathology, Nova Scotia Health Authority, Dalhousie University; Research Methods Unit, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.A. Legge, MD, Department of Medicine, Nova Scotia Health Authority, Dalhousie University; S. Doucette, MSc, Research Methods Unit, Nova Scotia Health Authority; J.G. Hanly, MD, FRCPC, Division of Rheumatology, Department of Medicine, and Department of Pathology, Nova Scotia Health Authority, Dalhousie University. john.hanly@cdha.nshealth.ca.
Abstract
OBJECTIVE: To describe organ damage accrual, predictors of damage progression, and effect on health-related quality of life (HRQOL) in patients with systemic lupus erythematosus (SLE). METHODS: A longitudinal database of patients who met the American College of Rheumatology (ACR) classification criteria for SLE was used. Annual assessments included the Systemic Lupus International Collaborating Clinics/ACR Damage Index (SDI) and the Medical Outcomes Study Short Form-36 (SF-36). The prognostic significance of demographic, disease-related, and treatment-related factors on damage progression was examined using multivariable Cox regression. The effect of changes in SDI scores on HRQOL, measured using the SF-36 summary and subscale scores, was assessed using linear mixed-effects modeling. RESULTS: There were 273 patients with SLE studied over a mean (SD) duration of followup of 7.3 (4.3) years. During followup, 126 (46.2%) had an increase in SDI scores. Patients with preexisting damage at baseline were more likely to have earlier damage progression (HR 2.09, 95% CI 1.44-3.01). Older age, ≥ 8 ACR classification criteria, immunosuppressive drugs, cigarette smoking, and higher mean serum C-reactive protein levels were associated with an earlier increase in SDI scores in multivariable analysis. In general, changes in SDI scores were associated with initial declines in SF-36 scores at the time that damage occurred, with subsequent change comparable to that seen in patients without damage progression. CONCLUSION: This study identified multiple risk factors, some modifiable, associated with damage progression in patients with SLE. The negative effect on HRQOL emphasizes the need for treatment strategies to reduce the risk of organ damage over time.
OBJECTIVE: To describe organ damage accrual, predictors of damage progression, and effect on health-related quality of life (HRQOL) in patients with systemic lupus erythematosus (SLE). METHODS: A longitudinal database of patients who met the American College of Rheumatology (ACR) classification criteria for SLE was used. Annual assessments included the Systemic Lupus International Collaborating Clinics/ACR Damage Index (SDI) and the Medical Outcomes Study Short Form-36 (SF-36). The prognostic significance of demographic, disease-related, and treatment-related factors on damage progression was examined using multivariable Cox regression. The effect of changes in SDI scores on HRQOL, measured using the SF-36 summary and subscale scores, was assessed using linear mixed-effects modeling. RESULTS: There were 273 patients with SLE studied over a mean (SD) duration of followup of 7.3 (4.3) years. During followup, 126 (46.2%) had an increase in SDI scores. Patients with preexisting damage at baseline were more likely to have earlier damage progression (HR 2.09, 95% CI 1.44-3.01). Older age, ≥ 8 ACR classification criteria, immunosuppressive drugs, cigarette smoking, and higher mean serum C-reactive protein levels were associated with an earlier increase in SDI scores in multivariable analysis. In general, changes in SDI scores were associated with initial declines in SF-36 scores at the time that damage occurred, with subsequent change comparable to that seen in patients without damage progression. CONCLUSION: This study identified multiple risk factors, some modifiable, associated with damage progression in patients with SLE. The negative effect on HRQOL emphasizes the need for treatment strategies to reduce the risk of organ damage over time.
Entities:
Keywords:
DAMAGE; HEALTH-RELATED QUALITY OF LIFE; SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Iñigo Rúa-Figueroa; Celia Erausquin; Celia Rua-Figueroa; Jesús González-Martín; Antonio Naranjo; Soledad Ojeda; Félix Francisco; Juan C Quevedo; Laura Cáceres; Ruben López; Martin Greco; Irene Altabás-González; Yanira Pérez; Francisco Rubiño; Carlos Rodríguez-Lozano Journal: Rheumatol Int Date: 2019-11-27 Impact factor: 2.631
Authors: N Groot; D Shaikhani; Y K O Teng; K de Leeuw; M Bijl; R J E M Dolhain; E Zirkzee; R Fritsch-Stork; I E M Bultink; S Kamphuis Journal: Arthritis Rheumatol Date: 2019-02 Impact factor: 10.995
Authors: Matteo Piga; Alberto Floris; Gerard Espinosa; Luísa Serpa Pinto; Nikolaos Kougkas; Andrea Lo Monaco; Giuseppe Lopalco; Ida Orlando; Vittorio Pirani; Ernestina Santos; George Bertsias; Luca Cantarini; Alberto Cauli; Ricard Cervera; João Correia; Marcello Govoni; Florenzo Iannone; Piergiorgio Neri; Ana Martins Silva; Carlos Vasconcelos; Monica Muntoni; Alessandro Mathieu Journal: RMD Open Date: 2020-07